We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

60 hedge funds and large institutions have $553M invested in Foghorn Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

64% more capital invested

Capital invested by funds: $338M → $553M (+$215M)

28% more funds holding

Funds holding: 47 → 60 (+13)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.42% less ownership

Funds ownership: 65.73% → 65.31% (-0.42%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

73% less call options, than puts

Call options by funds: $949K | Put options by funds: $3.52M

Holders
60
Holders Change
+13
Holders Change %
+27.66%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
20
Increased
13
Reduced
16
Closed
7
Calls
$949K
Puts
$3.52M
Net Calls
-$2.57M
Net Calls Change
-$2.57M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.51M
2
EI
EAM Investors
California
+$2.15M
3
EGI
EAM Global Investors
California
+$1.48M
4
DCM
Driehaus Capital Management
Illinois
+$1.29M
5
State Street
State Street
Massachusetts
+$1.11M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$6.14M
2
MIM
Monashee Investment Management
Massachusetts
-$4.18M
3
CC
Casdin Capital
New York
-$3M
4
KCM
Kingdon Capital Management
New York
-$2.18M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
51
SG Americas Securities
New York
$106K -$90.6K -6,301 -58%
CG
52
Cutler Group
California
$85K +$54K +3,754 New
TRCT
53
Tower Research Capital (TRC)
New York
$39K +$13.1K +913 +111%
Legal & General Group
54
Legal & General Group
United Kingdom
$37K -$977 -68 -4%
AIP
55
Ameritas Investment Partners
Nebraska
$35K – – –
WT
56
Washington Trust
Rhode Island
$34K +$21.6K +1,500 New
CAL
57
Capital Analysts LLC
Pennsylvania
$14K – – –
Osaic Holdings
58
Osaic Holdings
Arizona
$9K -$5.03K -350 -47%
QCG
59
Quadrant Capital Group
Ohio
$2K – – –
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$234 +$147K +10,246 New
CC
61
Casdin Capital
New York
– -$3M -215,000 Closed
SCM
62
Suvretta Capital Management
New York
– -$1.17M -84,000 Closed
PVI
63
Pura Vida Investments
New York
– -$949K -68,095 Closed
RE
64
RBC Europe
United Kingdom
– -$12K -860 Closed
US Bancorp
65
US Bancorp
Minnesota
– -$1K -73 Closed
1 2
3

FHTX Hedge Fund Activity: Q4 2021 in Review

60 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q4 2021, worth a combined $553M — up 64% from $338M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FHTX positions and 7 closed out — a net gain of 13 holders — while 13 added to existing stakes and 16 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $5.51M. The largest seller was Morgan Stanley, cutting an estimated $6.14M.

  • 60 institutional investors held Foghorn Therapeutics (FHTX) as of Q4 2021, up from 47 in Q3 2021.
  • Funds reported $553M of Foghorn Therapeutics stock for Q4 2021, up 64% quarter-over-quarter.
  • 20 funds opened new Foghorn Therapeutics positions in Q4 2021 and 7 closed out, a net change of +13 holders.
  • The largest Foghorn Therapeutics buyer in Q4 2021 was Point72 Asset Management, an estimated $5.51M added.
  • The largest Foghorn Therapeutics seller in Q4 2021 was Morgan Stanley, an estimated $6.14M sold.

Based on aggregated 13F filings for Q4 2021.